Last reviewed · How we verify
NCT05748574
Sleep Well Observation Study
NA trial testing Sleep Well Sachet in Sleep Disturbance in 50 participants. Completed in 3 August 2023.
3 June 2023
Quick facts
| Lead sponsor | A. Vogel AG |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 14 March 2023 |
| Primary completion | 3 June 2023 |
| Estimated completion | 3 August 2023 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Sleep Well Sachet
Conditions studied
- Sleep Disturbance — all drugs for Sleep Disturbance →
Sponsor
A. Vogel AG — full company profile →
Who can join
Adults 18 to 50, any sex, with Sleep Disturbance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Insomnia is characterized by the recurring difficulty to fall or remain asleep despite motivation and means to do so. People with insomnia also experience excessive daytime sleepiness and other cognitive impairments while they are awake. Facing the situation mentioned and realizing that especially early preventive measures are needed to fight the increasing costs for treatment of sleep related diseases, effective nutrients might be a good and safe option to improve sleep quality.This single-arm, open-label, prospective, observational exploratory pilot study aims at collecting first data on efficacy and safety of "Sleep Well".
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05748574
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sleep Disturbance
Currently open trials in the same condition.
- NCT07503223 — Sleep Optimization With Acoustic Therapy · NA · recruiting
- NCT07464626 — Virtual vs Physical Art Therapy for Anxiety, Psychological Well-being, and Sleep Quality in Colorectal Cancer Patients · NA · recruiting
- NCT07386691 — Comparing Effect of Intradialytic Aerobic Exercise Versus Incentive Spirometer on Fatigue and Sleep Quality Among Hemodi · NA · active not recruiting
- NCT07354776 — Effect of Isometric Neck Exercises on Cervicogenic Headache, Cortisol, and BDNF in Adolescents With Smartphone Addiction · NA · recruiting
- NCT07119268 — SPARK Healthy Sleep · NA · recruiting
Other A. Vogel AG trials
Trials by the same sponsor.
- NCT06795776 — Eschscholzia Study · Phase 3 · completed
- NCT05757050 — Mental Balance Study · NA · completed
- NCT04999098 — Echinaforce COVID-19 Shedding Study · Phase 4 · terminated
- NCT05002179 — Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections · Phase 4 · completed
- NCT04139681 — Safety and Efficacy of the Sore Throat Lozenges to Treat Acute Sore Throats · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05748574 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by A. Vogel AG
- Last refreshed: 6 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05748574.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing